Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

Tennis legend Serena Williams has sparked conversations around fitness and health after reports of her weight loss journey ...

Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...

Serena Williams, the tennis legend with 23 Grand Slam singles titles, has always been admired for her athletic prowess and ...

Fat jabbers all over the country are in meltdown following the news that Mounjaro, the most popular and effective of all the ...

Tennis legend Serena Williams, 43, has explained how she has managed to shed a remarkable 31 pounds over the past 18 months ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.